Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome. World J Clin Cases 2024; 12(3): 503-516 [PMID: 38322471 DOI: 10.12998/wjcc.v12.i3.503]
Corresponding Author of This Article
Wiem Manoubi, BSc, Research Scientist, Researcher, Laboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Street Ibn El Jazzar, Sousse 4000, Tunisia. wiem.manoubi@yahoo.fr
Research Domain of This Article
Clinical Neurology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jan 26, 2024; 12(3): 503-516 Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.503
Table 1 Clinical characteristics of patients with suspected Angelman syndrome
Number of patients
Percentage (%)
Gender
33 male; 17 female
Hypotonia
100
Neck support
(32/50)
64
Walk without support
(21/50)
42
Sitting without support
(38/50)
76
Absent speech
(40/50)
80
Developmental delay
50/50)
100
Severe mental retardation
(50/50)
100
Microcephaly
(44/50)
88
Macrostomia
(40/50)
80
Clinical seizures
(44/50)
88
Occipital groove
(45/50)
90
Protruding tongue
(43/50)
86
Wide-spaced teeth
(35/50)
70
Prognathism
(40/50)
80
Unusually light hair or skin color
(13/50)
26
Easily provoked laughter
(50/50)
100
Hyperactivity
(48/50)
96
Gastro-esophageal reflux
(40/50)
80
Ataxic movements
(48/50)
96
Frequent drooling
(47/50)
94
History of sleep difficulties
(45/50)
90
Fascination with water
(40/50)
80
Autistic behavior
(14/50)
28
Table 2 Primer pairs used for single strand conformation polymorphism
Exon and primers
Forward and reverse primers (5’->3’)
Region
Annealing temperature (℃)
7
Ex7F
GCC ACC TGA TCT GAC CAC T
Intron
52
Ex7R
GCA GTC TAG GGC AAC TCA AA
Intron
8
Ex8AF
GCC TTG ATG ATA TGT TGA GC
Intron
55
Ex8AR
AAT TCT AGC GCC TTT CTT GT
Exon
Ex8BF
GCC TGC ACG AAT GAG TTT TGT
Exon
55
Ex8BR
AGT TAT TAT TCC TGT CCG TTA CC
Intron
9
Ex9AF
TGT TTG GCT GTT TTA CTT TTA GA
Intron
55
Ex9AR
GGC ATC AAT ATC CAC AGA CAC A
Exon
Ex9BF
AGA AGC ATC TTC CTC AAG G
Exon
55
Ex9BR
CAC TTC CCC TCC CAC TAC
Exon
Ex9CF
CAA TGA ATT TAA CAG TCG A
Exon
55
Ex9CR
CAT CAT CTA TGA TAT GGT CAC G
Exon
Ex9DF
CGC ATG TAC AGT GAA CGA AGA A
Exon
55
Ex9DR
TGC ACA GGA ACA ACA AAA GTA T
Intron
10
Ex10F
GTT TGC TTT CTG TTT CCA TTT AC
Intron
52
Ex10R
ATC CTT CTT TTG CTG CTC TTC
Intron
11
Ex11F
CAA TGT TGC ATG CCT AAT TAC A
Intron
GGT ACT TCG GTC AGA TTA AAA C
Intron
12
Ex12F
GGG GAC TGG AGG GAT ACT GT
Intron
55
ACA TGC TTT GAA AGT GTT AAT G
Intron
13
Ex13F
GAA ATT GTT AAG AAG TAG GTG
Intron
52
Ex13R
ATA TGT CTT AGT TAT CTG CTA
Intron
14
Ex14F
AGG TGT CTG CAA AAA GTC
Intron
55
Ex14R
TTA GCT CTG AAA AAT GGT G
Intron
15
Ex15F
ATA ATG AAT GCC AAA CTG AA
Intron
55
Ex15R
ATA TGT ATG TGA CGA GGA ATG
Intron
16
Ex16F
CCC ATG ACT TAC AGT TTT CCT G
Intron
55
Ex16R
AAG AAG GGA GGC ACA GAC AT
Intron
Table 3 Ubiquitin-protein ligase E3A polymorphisms detected in our group of clinically diagnosed Angelman syndrome patients. The nucleotide and codon positions refer to the complete ubiquitin-protein ligase E3A cDNA sequence
Four common polymorphisms
New polymorphisms
c.2064+9T>C → rs79328837 (intro13)
c.2220+14T>C (intron14)
c.1713A>G → RS34670662 (exon 11)
c.30-47_30-46 insT (Exon7)
c.2221-40_2221-38delGTA, RS149854051 (intron 14)
c.2507+43T>A (Exon15)
c.486A>T; p.Ala162 =, RS28528079 (exon9A)
Table 4 Identified exonic variants in the first consanguineous family
Gene (gene)
SHPRH
SLC30A9
HBS1L
TAAR6
TAAR2
SASH1
LOC100287896
PCF11
ANKRD42
PDGFD
DIXDC1
Chromosome
6
4
6
6
6
6
11
11
11
11
11
Location (varLocation)
Exonic
Intronic
intronic
Exonic
Exonic
Exonic
Exonic
Exotic
Exonic
Exonic
Exonic
Effect (codingEffect)
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
Nonsynonymous
cDNA (cNomen)
c.4331C>T
c.528-7T>C
c.2043+5T>G
c.865C>T
c.467C>T
c.1126C>T
c.4C>T
c.3355C>T
c.676A>G
c.7C>G
c.226G>A
Protein (pNomen)
p.A1444V
p.P289S
p.T156I
p.P376S
p.R2C
p.H1119Y [Histidine (His)- Tyrosine (Tyr)]
p.N226D [Asparagine (Asn)- Aspartic Acid (Asp)]
p.R3G [Arginine (Arg)- Glycine (Gly)]
p.G76S [Glycine (Gly)- Serine (Ser)]
Pathogenicity
09/11
This mutation probably has no impact on splicing
Activation of an intronic cryptic donor site.
07/11
10/11
09/11
08/11
09/11
03/Nov
0/11
Potential alteration of splicing
GME Variome (%)
Not available
Not available
Not available
0.1
Not available
Not available
Not available
0.1
0.1
0.1
Not available
Gnomad browser (%)
0.0008
0.04
0.2
0.006
0.001
0.001
0.4
0.2
0.3
0.01
0.002
Table 5 Identified exonic variants in the second consanguineous family
Gene (gene)
KMT5A
KMT5A
STK36
PIK3CB
GPR149
RARRES1
KPNA4
NOS1
CAMKK2
WDR66
SBNO1
Chromosome
12
12
2
3
3
3
3
12
12
12
12
Location (varLocation)
Exonic
Exonic
Exonic
Exonic
Exonic
Exonic
Exonic
Exonic
Exonic
Exonic
Intronic
Effect (codingEffect)
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
Non-synonymous
cDNA (cNomen)
c.904>C
c.995>C
c.2516 A
c.2150>G
c.1404A>C
c.230C>T
c.1103>G
c.1922>T
c.1612_1614dupAAA
c.196_197insAGAAAGAGGAGGAGG
c.3220+5C>G
Protein (pNomen)
p.C302R
p.L332P
p.R839Q
p.N717S
p.R468S
p.P77L
p.N368S
p.A641V
p.K538dup
p.E65_G66insEKEEE
No significant splicing motif alteration detected. This mutation probably has no impact on splicing
Pathogenicity
03/11
10/11
06/11
01/11
01/11
10/11
03/11
09/11
01/11
01/11
Not available
GME Variome (%)
Not available
Not available
0.05
0.9
0.1
Not available
Not available
Not available
Not available
Not available
0.01
Gnomad browser (%)
Not available
Not available
0.7
0.1
0.04
0.004
0.003
Not available
12
Not available
0.01
Table 6 Gene expression in both Family 1 and Family 2
Gene
Function
Gene expression in Family 1
TAAR2
Relevance to brain function and behavior, including schizophrenia, depression, anxiety, and drug addiction
CITED2
Gene is identified in human endothelial cells and neonatal brain. It is implicated in the development of the heart and neural tube
HPRH
Ubiquitously expressed protein that contains motifs characteristics of several DNA repair proteins, transcription factors, and helicases. A possible candidate for the tumor suppressor gene
SASH1
Highly expressed in brain, heart, lung, ovary, and kidney. It is also identified as a candidate tumor suppressor gene in breast cancer
DIXDC1
Highly expressed in the brain and in specific brain regions; important in embryonic cortical development
SLC30A9
Shows ubiquitous expression in various human tissues, with high expression in the fetal brain, cerebellum, skeletal muscle, and kidney. Sub-cellular localization studies suggested that it is expressed in the vesicular cytosolic compartment, possibly in the endoplasmic reticulum
Gene expression in Family 2
KMT5A
Is a lysine methyl-transferase that predominantly mono-methylates lysine-20 (K20) of histone H4
SETD8
Influences transcriptional regulation, heterochromatin formation, genomic stability, cell cycle progression, and development
STK36
Important for brain development
PIK3CB
Plays a role in systemic insulin-like growth factor (IGF1) regulation and human longevity
RARRES1
Implicated in hyperproliferation, inflammatory skin diseases and, prostate cancer
GPR149
Increases fertility in mice, and causes prostatic cancer
NOS1
Important for the brain and peripheral nervous system
SBNO1
Implicated in cognition and psychoses, essential roles in vertebrate brain development
Citation: Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome. World J Clin Cases 2024; 12(3): 503-516